Charles N. York II - Jul 18, 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Stock symbol
DAWN
Transactions as of
Jul 18, 2022
Transactions value $
-$50,000
Form type
4
Date filed
7/20/2022, 06:18 PM
Previous filing
Jul 12, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale -$50K -2.5K -0.75% $20.00 331K Jul 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.